Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a mindfulness app for pain and low mood after childbirth

Tests a self-guided phone mindfulness program in adults after cesarean delivery.

Plain-language title generated from the registry record
Registry title: Maternal Mindfulness: Depression and Postpartum Pain

Key facts

Where
Champaign, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT05400382, who can take part

Where in United States

  • University of Illinois Urbana-ChampaignChampaign, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Illinois at Urbana-Champaign
Trial code
NCT05400382
Record updated
6 August 2026
Original description
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.Read full original descriptionShow less

Maternal Mindfulness to Prevent Depression and Reduce Postpartum Pain (MaMiDaPP) Intervention

This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.

Women must self-identify as Latina/Latinx/Hispanic, Asian, African American, or non-Hispanic White; Scheduled to undergo a planned cesarean delivery; Be of 18-45 years of age; Have a singleton pregnancy; Score between 5 and 13 on the Edinburgh Postnatal Depression Scale (EPDS); A history of depression; Have no chronic pain condition (e.g., fibromyalgia); Own a computer, smartphone, or tablet; Have a reliable internet access to complete the online surveys; Be proficient in English or Spanish.

ClinicalTrials.gov NCT05400382